Cytokinetics CYTK PA — Lessee Operating Lease Discount Rate
Discontinued — last reported Q4 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseDiscountRate.
The official record: Cytokinetics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's pa — lessee operating lease discount rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytokinetics's PA — lessee operating lease discount rate?
- Cytokinetics (CYTK) reported PA — lessee operating lease discount rate of 8.9% in Q4 2025.
- What does PA — lessee operating lease discount rate mean?
- The interest rate used to calculate the present value of future lease payments.
- How do you interpret PA — lessee operating lease discount rate?
- A higher rate increases the cost of capital for leasing, while a lower rate reflects more favorable financing terms or a stronger credit profile.
- How does PA — lessee operating lease discount rate compare across companies?
- Comparable to corporate borrowing rates and industry-specific lease financing benchmarks.